首页> 外文期刊>JMIR Research Protocols >Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (PCI) According to the 24/7 Primary PCI Service Registry in Iran: Protocol for a Cross-Sectional Study
【24h】

Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (PCI) According to the 24/7 Primary PCI Service Registry in Iran: Protocol for a Cross-Sectional Study

机译:根据伊朗的24/7主要PCI服务注册中心,经历了首次经皮冠状动脉介入治疗(PCI)的ST段抬高型心肌梗死患者的治疗时间和院内重大不良心脏事件:一项跨领域研究的协议

获取原文
           

摘要

Background Patients with ST-segment elevation myocardial infarction (STEMI) experience major adverse cardiac events (MACEs) following primary percutaneous coronary intervention (PCI). Although the relationship between time to treatment (eg, door-to-balloon time, symptom onset-to-balloon time, and symptom onset-to-door time) and 1-month all-cause mortality was assessed previously, its relationship with in-hospital MACEs and the effect of some clinical characteristics on this relationship were not considered. Furthermore, previous studies that were conducted in developed countries with a different quality of care cannot be applied in Iran, as Iran is a developing country and the studies were not performed according to the 24/7 primary PCI service registry. Objective The objective of this study protocol is to determine the relationship between time to treatment and in-hospital MACEs. Methods This cross-sectional study will take place at the Tehran Heart Center (THC), which is affiliated with Tehran University of Medical Sciences (TUMS) in Tehran, Iran. Data related to patients with STEMI, who underwent primary PCI between March 2015 and March 2019, that have been prospectively recorded in the THC’s 24/7 primary PCI service registry will be analyzed. The study outcome is the occurrence of in-hospital MACEs. Data analysis will be conducted using SPSS for Windows, version 16.0 (SPSS Inc). We will perform chi-square tests, independent-samples t tests, or the Mann-Whitney U test, as well as univariate and multivariate binary logistic regression with a significance level of less than .05 and 95% CI for odds ratios. Results From March 2015 to September 2017, 1586 patients were included in the THC service registry, consecutively. We will conduct a retrospective analysis of this registry on patient entries between March 2015 and March 2019 and data will be analyzed and published by the end of 2019. Conclusions To our knowledge, this is the first observational study based on the 24/7 primary PCI service registry in Iran. The findings of this study may reveal current problems regarding time to treatment in STEMI management in the THC. Results from this study may help determine appropriate preventive strategies that need to be applied in order to reduce time-to-treatment delays and improve patients’ outcomes following primary PCI in the setting of STEMI at the THC and similar clinical centers.
机译:背景技术ST段抬高型心肌梗死(STEMI)患者在经皮经皮冠状动脉介入治疗(PCI)后会出现严重的不良心脏事件(MACE)。尽管先前已评估了治疗时间(如上气球时间,症状发作-气球时间和症状发作-上门时间)与1个月全因死亡率之间的关系,但其与未考虑医院MACE和某些临床特征对该关系的影响。此外,由于伊朗是发展中国家,并且以前没有按照24/7主要PCI服务注册中心进行过研究,因此以前在发达国家进行的具有不同护理质量的研究不能在伊朗使用。目的本研究方案的目的是确定治疗时间与院内MACE之间的关系。方法:这项横断面研究将在伊朗德黑兰德黑兰医学科学大学(TUMS)所属的德黑兰心脏中心(THC)进行。我们将分析2015年3月至2019年3月间接受过主PCI的STEMI患者的相关数据,这些数据已预先记录在THC的24/7主PCI服务注册表中。研究结果是院内MACE的发生。数据分析将使用Windows SPSS 16.0版(SPSS Inc)进行。我们将执行卡方检验,独立样本t检验或Mann-Whitney U检验,以及单变量和多变量二元logistic回归,其显着性水平低于0.05,CI值比小于95%。结果从2015年3月至2017年9月,THC服务登记表中连续纳入1586例患者。我们将在2015年3月至2019年3月之间对该登记册进行回顾性分析,并在2019年底之前对数据进行分析和发布。结论据我们所知,这是基于24/7主PCI的第一项观察性研究。伊朗的服务注册中心。这项研究的发现可能揭示了THC STEMI管理中有关治疗时间的当前问题。这项研究的结果可能有助于确定适当的预防策略,以减少在THC和类似临床中心的STEMI情况下初次PCI后治疗的延迟时间并改善患者的预后。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号